Two previously undescribed monoterpenoid indole alkaloids, N-formylyunnanensine (1) and scholaphylline (2), along with eight known alkaloids, namely, 19,20-E-vallesamine (3), 19,20-Z-vallesamine (4), 19,20-E-vallesamine N-oxide (5), 6,7-seco-19,20α-epoxyangustilobine B (6), 16R-19,20-E-isositsirikine (7), N-demethylalstogustine N-oxide (8), E-vallesiachotamine (9), and Z-vallesiachotamine (10), were isolated from the bark of Alstonia scholaris. Alkaloid 1 was determined to be the N-formyl derivative of the known alkaloid, yunnanensine, comprising a pair of inseparable E/Z-formamide rotamers, while scholaphylline (2) was identified as the first member of the secostemmadenine-yunnanensine type bisindole alkaloid. The structures of these alkaloids and their absolute configurations were established based on detailed analysis of the spectroscopic data in conjunction with the TDDFT-ECD method. A possible biogenetic pathway to 1 and 2, involving stemmadenine as the primary precursor, was proposed. Scholaphylline (2) showed modest cytotoxicity against Panc1 (IC50 27.7 ± 5.1 µM), MDA-MB-231 (IC50 32.0 ± 2.2 µM), and MDA-MB-468 (IC50 34.1 ± 3.3 µM) cancer cell lines, while N-formylyunnanensine (1) did not show appreciable cytotoxicity against any of the tested cell lines.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: